The effect of phytoestrogens on symptoms of premenstrual syndrome (PMS) and cognitive performance
ISRCTN | ISRCTN94691299 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN94691299 |
Secondary identifying numbers | N0436118179 |
- Submission date
- 12/09/2003
- Registration date
- 12/09/2003
- Last edited
- 20/06/2008
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Urological and Genital Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr L Dye
Scientific
Scientific
Psychology Department
Leeds
LS2 9LN
United Kingdom
Phone | +44 0113 243 1751 |
---|---|
louised@psychology.leeds.ac.uk |
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Not specified |
Study type | Not Specified |
Scientific title | |
Study objectives | A randomised double blind, placebo controlled trial of the effects of supplementation of phytoestrogens (PO) (isoflavones - 100 mg/day) on premenstrual symptoms and cognitive performance in 50 women with at least mild premenstrual symptoms for two menstrual cycles per condition is proposed. The main objective is to determine whether PO are more beneficial than placebo supplements in relieving symptoms of PMS and to assess whether the consumption of PO affects cognitive performance in the premenstrual and follicular phases of the menstrual cycle. |
Ethics approval(s) | Not provided at time of registration |
Health condition(s) or problem(s) studied | Urological and Genital Diseases: Premenstrual syndrome (PMS) |
Intervention | Questionnaire. Randomised controlled trial. Random allocation to: 1. Supplementation with phytoestrogens 2. Placebo |
Intervention type | Drug |
Pharmaceutical study type(s) | |
Phase | Not Specified |
Drug / device / biological / vaccine name(s) | phytoestrogens |
Primary outcome measure | 1. Mood questionnaires, urine and blood test. 2. Cognitive function tests. |
Secondary outcome measures | Not provided at time of registration |
Overall study start date | 01/04/2002 |
Completion date | 31/12/2007 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Sex | Female |
Target number of participants | 50 |
Key inclusion criteria | 50 premenstrual women - university based study of staff, student volunteers and women from surrounding areas within Yorkshire. |
Key exclusion criteria | Not provided at time of registration |
Date of first enrolment | 01/04/2002 |
Date of final enrolment | 31/12/2007 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Psychology Department
Leeds
LS2 9LN
United Kingdom
LS2 9LN
United Kingdom
Sponsor information
Department of Health (UK)
Government
Government
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
Website | http://www.doh.gov.uk |
---|
Funders
Funder type
Government
Leeds Teaching Hospitals NHS Trust (UK)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | results on symptom effects | 01/05/2005 | Yes | No |